Terms and Agreement
Please agree to the terms to continue using the chat feature.
Date | Type | Amount Purchased | Purchaser |
---|---|---|---|
2024-04-17 | Sale | -413507.00 | Fortress Biotech, Inc. |
2024-01-03 | Sale | -2101496.00 | Fortress Biotech, Inc. |
2023-12-13 | Sale | -264000.00 | Davidow Robert L |
2023-09-12 | Buy | 418410.00 | Fortress Biotech, Inc. |
2023-09-12 | Buy | 348675.00 | ROSENWALD LINDSAY A MD |
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Aug 09, 2024 |
10-q | Quarterly Reports | 54 | Aug 09, 2024 |
8-k | 8K-related | 15 | Jun 26, 2024 |
8-k | 8K-related | 14 | May 23, 2024 |
10-q | Quarterly Reports | 56 | May 15, 2024 |
8-k | 8K-related | 16 | May 15, 2024 |
8-k | 8K-related | 16 | May 13, 2024 |
def | Proxies and info statements | 5 | May 06, 2024 |
8-k | 8K-related | 20 | May 01, 2024 |
8-k | 8K-related | 17 | Apr 26, 2024 |
Red Chat is here to summarize the SEC filing data on ATXI
Please agree to the terms to continue using the chat feature.